drugset
drugset / Trial / NCT05999513

A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers

NCT05999513 ↗

Phase 1 Completed 24 enrolled Arcus Biosciences, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan tablet versus the casdatifan capsule, and to evaluate the effect of food on the single-dose PK of casdatifan tablet in healthy adult volunteers.

Timeline

Start
2023-08-21
Primary completion
2023-10-31
Completion
2023-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Casdatifan Small molecule — —

Indications

No indication recorded.